Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Clinical trial NCT00977665 · COMPLETED

Trial details

NCT number: NCT00977665
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple System Atrophy

Start date: 2009-12-01
Primary completion: 2011-10-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.